Eculizumab Intravenous and Insulin Degludec (U-100) Prefilled Pens
Determining the interaction of Eculizumab Intravenous and Insulin Degludec (U-100) Prefilled Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: eculizumab
Brand name: Soliris
Synonyms: Eculizumab
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Eculizumab Intravenous-Insulin Degludec (U-100) Vials
- Eculizumab Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Eculizumab Intravenous-Insulin degludec and liraglutide
- Eculizumab Intravenous-Insulin degludec and liraglutide Subcutaneous
- Eculizumab Intravenous-Insulin degludec Subcutaneous
- Eculizumab Intravenous-Insulin detemir
- Insulin Degludec (U-100) Prefilled Pens-Ed A-Hist
- Insulin Degludec (U-100) Prefilled Pens-Ed A-Hist DM
- Insulin Degludec (U-100) Prefilled Pens-Ed ChlorPed
- Insulin Degludec (U-100) Prefilled Pens-Ed ChlorPed D
- Insulin Degludec (U-100) Prefilled Pens-Ed Cyte F
- Insulin Degludec (U-100) Prefilled Pens-Ed-Chlor Ped Jr